2014 Archive

February 2014

A cure for diabetes could just be skin-deep: UCSF, Gladstone Institutes scientists grow healthy beta cells -
Collaborating with researchers from the Gladstone Institutes in San Francisco,  Matthias Hebrok, PhD,  director of the Diabetes Center at the University of California, San Francisco,  co-authored a ground-breaking study this week on reprogramming skin cells into insulin-producing pancreas cells – a major step toward finding a cure for type 1 diabetes.
UCSF Scientists Receive Grant to Continue Stem Cell Research for Diabetes Cure: Funds will enable further research for treating type 1 diabetes -
This week, the California Institute for Regenerative Medicine awarded two members of the University of California, San Francisco Diabetes Center -- immunologist Mark Anderson, MD, PhD, and stem cell researcher Matthias Hebrok, PhD -- a grant to continue their breakthrough research on thymic cells, a key component to the immune system.

January 2014

Progress Continues in Islet Transplantation, Immunosuppression Alternatives & New Sources of Cells -
At the 14th World Congress of the International Pancreas and Islet Transplant Association (IPITA), UCSF faculty presented the latest in islet transplantation, and shared exciting progress in stopping islet and tissue rejection through regulatory T cells (Tregs) and creating new sources of insulin-producing beta cells.
Diabetes Center Researcher Identifies Gene Responsible for Control of Brown Fat Development -
Shingo Kajimura, PhD, a Diabetes Center at UCSF faculty member and a member of the UCSF Department of Cell and Tissue Biology, has identified a gene vital to the development and function of brown fat cells.
Behavioral Study Proves that Diabetes Distress is Highly Responsive to Intervention -
A recent study in non-clinically depressed adults with type 2 diabetes compared three interventions to reduce Diabetes Distress and improve self-management.
UCSF Launches GleeT1D - New Clinical Trial for Type 1 Diabetes Patients Diagnosed Within 100 Days -
 A new, phase II clinical trial is being launched to evaluate the safety and efficacy of imatinib as a novel therapy for new-onset type 1 diabetes.
Novel Research to Evaluate Metformin and Insulin Therapy in Overweight Adolescents With Type 1 -
T1D Exchange, the first program of the new nonprofit organization Unitio, has received funding from JDRF to study the use of metformin—a drug used as first-line treatment for type 2 diabetes—in combination with standard insulin therapy in overweight adolescents with type 1 diabetes.